A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura

Pediatric Blood and Cancer

Volumn 47, Issue 5 SUPPL., 2006, Pages 717-720

  Kjaersgaard, Mimi ^a,b   Hasle, Henrik ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Administration form; Anti D; Children; Effect; ITP

Indexed keywords

IMMUNOGLOBULIN G; PREDNISOLONE; RHESUS D ANTIBODY;

BLEEDING; CHILL; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEVER; HEADACHE; HEMOLYSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; KIDNEY FAILURE; NAUSEA; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT; VOMITING;

CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOANTIBODIES; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 33748510808     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20996     Document Type: Review

References (26)

1. Salama A, Kiefel V, Amberg R, et al. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies [anti-Rh0(D)]. Blut 1984;49:29-35.
2. Ambriz-Fernandez R, Martinez-Murillo C, Quintana-Gonzalez S, et al. Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG. Arch Med Res 2002;33:536-540.
3. Andrew M, Blanchette VS, Adams M, et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1992;120:522-527.
4. Becker T, Kuenzlen E, Salama A, et al. Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D). Eur J Pediatr 1986;145:166-169.
5. Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-707.
6. Borgna-Pignatti C, Battisti L, Zecca M, et al. Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins. Br J Haematol 1994;88:618-620.
7. Bussel JB, Graziano JN, Kimberly RP, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect. Blood 1991;77:1884-1893.
8. Caglayan S, Aksit S, Yaprak I, et al. Steroid-free interval with anti-D in chronic idiopathic thrombocytopenic purpura. Acta Paediatr Jpn 1993;35:36-38.
9. Yaprak I, Caglayan S, Kansoy S, et al. Long-term use of anti-D in chronic idiopathic thrombocytopenic purpura. Turk J Pediatr 1994;36:43-47.
10. El Alfy MS, Mokhtar GM, El-Laboudy MA, et al. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. Acta Haematol 2006;115:46-52.
11. Freiberg A, Mauger D. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Semin Hematol 1998;35:23-27.
12. Krishnamurti L, Charan VD, Desai N, et al. Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. Indian J Pediatr 1994;61:179-182.
13. Kumar M, Vik TA, Johnson CS, et al. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura. Am J Hematol 2005;78:181-187.
14. Meyer O, Kiesewetter H, Hermsen M, et al. Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia. Eur J Haematol 2004;73:71-72.
15. Monteleone PM, Vander Heyden MA, Steele DA, et al. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: A pilot study. Haematologica 2000;85:887-888.
16. Moser AM, Shalev H, Kapelushnik J. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 2002;19:407-411.
17. Newman GC, Novoa MV, Fodero EM, et al. A dose of 75 microg/kg/d of i.V. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001;112:1076-1078.
18. Ruiz-Arguelles GJ, Lopez-Martinez B, Flores-Martinez J, et al. An affordable Fc-receptor blockade method to treat patients with chronic refractory autoimmune thrombocytopenic purpura. Haematologica 2001;86:552-553.
19. Sajid R, Adil SN, Fadoo Z, et al. Use of intravenous anti-D in patients with refractory and relapsed immune thrombocytopenic purpura. J Pak Med Assoc 2003;53:537-539.
20. Scaradavou A, Woo B, Woloski BM, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients. Blood 1997;89:2689-2700.
21. Tarantino MD, Madden RM, Fennewald DL, et al. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 1999;134:21-26.
22. Kees-Folts D, Abt AB, Domen RE, et al. Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura. Pediatr Nephrol 2002;17:91-96.
23. Gaines AR. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000;95:2523-2529.
24. Roberti I, Bagtas JF, Reisman L, et al. Severe acute renal failure due to hemoglobinuria after use of WinRho for the treatment of idiopathic thrombocytopenic purpura. Clin Pediatr (Phila) 2001;40:61-62.
25. Levendoglu-Tugal O, Jayabose S. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia. J Pediatr Hematol Oncol 2001;23:460-463.
26. Gardulf A, Hammarstrom L, Smith CI. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991;338:162-166.